Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2020

01-12-2020 | Prostate Cancer | Research article

Spatio-temporal mapping of breast and prostate cancers in South Iran from 2014 to 2017

Authors: Mahdieh Montazeri, Benyamin Hoseini, Neda Firouraghi, Fatemeh Kiani, Hosein Raouf-Mobini, Adele Biabangard, Ali Dadashi, Vahideh Zolfaghari, Leila Ahmadian, Saeid Eslami, Robert Bergquist, Nasser Bagheri, Behzad Kiani

Published in: BMC Cancer | Issue 1/2020

Login to get access

Abstract

Background

The most common gender-specific malignancies are cancers of the breast and the prostate. In developing countries, cancer screening of all at risk is impractical because of healthcare resource limitations. Thus, determining high-risk areas might be an important first screening step. This study explores incidence patterns of potential high-risk clusters of breast and prostate cancers in southern Iran.

Methods

This cross-sectional study was conducted in the province of Kerman, South Iran. Patient data were aggregated at the county and district levels calculating the incidence rate per 100,000 people both for cancers of the breast and the prostate. We used the natural-break classification with five classes to produce descriptive maps. A spatial clustering analysis (Anselin Local Moran’s I) was used to identify potential clusters and outliers in the pattern of these cancers from 2014 to 2017.

Results

There were 1350 breast cancer patients (including, 42 male cases) and 478 prostate cancer patients in the province of Kerman, Iran during the study period. After 45 years of age, the number of men with diagnosed prostate cancer increased similarly to that of breast cancer for women after 25 years of age. The age-standardised incidence rate of breast cancer for women showed an increase from 29.93 to 32.27 cases per 100,000 people and that of prostate cancer from 13.93 to 15.47 cases per 100,000 during 2014–2017. Cluster analysis at the county level identified high-high clusters of breast cancer in the north-western part of the province for all years studied, but the analysis at the district level showed high-high clusters for only two of the years. With regard to prostate cancer, cluster analysis at the county and district levels identified high-high clusters in this area of the province for two of the study years.

Conclusions

North-western Kerman had a significantly higher incidence rate of both breast and prostate cancer than the average, which should help in designing tailored screening and surveillance systems. Furthermore, this study generates new hypotheses regarding the potential relationship between increased incidence of cancers in certain geographical areas and environmental risk factors.
Appendix
Available only for authorised users
Literature
1.
Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1459–544.CrossRef
2.
3.
Danaei G, Vander Hoorn S, Lopez AD, Murray CJ, Ezzati M. Group CRAc. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet. 2005;366(9499):1784–93.PubMedCrossRef
4.
5.
Sankaranarayanan R, Swaminathan R, Brenner H, Chen K, Chia KS, Chen JG, et al. Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol. 2010;11(2):165–73.PubMedCrossRef
6.
Rajaraman P, Anderson BO, Basu P, Belinson JL, D'Cruz A, Dhillon PK, et al. Recommendations for screening and early detection of common cancers in India. Lancet Oncol. 2015;16(7):e352–e61.PubMedCrossRef
7.
Lofters AK, Gozdyra P, Lobb R. Using geographic methods to inform cancer screening interventions for south Asians in Ontario, Canada. BMC Public Health. 2013;13(1):395.PubMedPubMedCentralCrossRef
8.
Ghoncheh M, Pournamdar Z, Salehiniya H. Incidence and mortality and epidemiology of breast cancer in the world. Asian Pac J Cancer Prev. 2016;17(S3):43–6.PubMedCrossRef
9.
Murillo-Zamora E, Mendoza-Cano O, Ríos-Silva M, Sánchez-Piña RA, Higareda-Almaraz MA, Higareda-Almaraz E, et al. Disability-adjusted life years for Cancer in 2010–2014: a regional approach in Mexico. Int J Environ Res Public Health. 2018;15(5):864.PubMedCentralCrossRef
10.
Tedaldi G, Tebaldi M, Zampiga V, Danesi R, Arcangeli V, Ravegnani M, et al. Multiple-gene panel analysis in a case series of 255 women with hereditary breast and ovarian cancer. Oncotarget. 2017;8(29):47064.PubMedPubMedCentralCrossRef
11.
Hemminki K, Zhang H, Czene K. Socioeconomic factors in cancer in Sweden. Int J Cancer. 2003;105(5):692–700.PubMedCrossRef
12.
Kulhánová I, Znaor A, Shield KD, Arnold M, Vignat J, Charafeddine M, et al. Proportion of cancers attributable to major lifestyle and environmental risk factors in the eastern Mediterranean region. Int J Cancer. 2020;146(3):646–56.PubMedCrossRef
13.
Coyle YM. The effect of environment on breast cancer risk. Breast Cancer Res Treat. 2004;84(3):273–88.PubMedCrossRef
14.
15.
Wang M, Wasserman E, Geyer N, Carroll RM, Zhao S, Zhang L, et al. Spatial patterns in prostate Cancer-specific mortality in Pennsylvania using Pennsylvania Cancer registry data, 2004–2014. BMC Cancer. 2020;20(1):394.PubMedPubMedCentralCrossRef
16.
Wang M, Matthews SA, Iskandarani K, Li Y, Li Z, Chinchilli VM, et al. Spatial-temporal analysis of prostate cancer incidence from the Pennsylvania Cancer registry, 2000-2011. Geospat Health. 2017;12(2):611.PubMedPubMedCentral
17.
18.
19.
Sahar L, Foster SL, Sherman RL, Henry KA, Goldberg DW, Stinchcomb DG, et al. GIScience and cancer: state of the art and trends for cancer surveillance and epidemiology. Cancer. 2019;125(15):2544–60.PubMed
20.
Graves BA. Integrative literature review: a review of literature related to geographical information systems, healthcare access, and health outcomes. Perspect Health Inf Manag. 2008;5:11. PMID: 18698429.
21.
Goshayeshi L, Pourahmadi A, Ghayour-Mobarhan M, Hashtarkhani S, Karimian S, Shahhosein Dastjerdi R, et al. Colorectal cancer risk factors in north-eastern Iran: A retrospective cross-sectional study based on geographical information systems, spatial autocorrelation and regression analysis. Geospat Health. 2019;14(2):219–28.CrossRef
22.
Hashtarkhani S, Kiani B, Bergquist R, Bagheri N, VafaeiNejad R, Tara M. An age-integrated approach to improve measurement of potential spatial accessibility to emergency medical services for urban areas. Int J Health Plann Manag. 2020;35(3):788–98.CrossRef
23.
Kiani B, Bagheri N, Tara A, Hoseini B, Tara M. Haemodialysis services in the northeastern region of Iran. Geospat Health. 2017;12(1):130–6.CrossRef
24.
Halimi L, Bagheri N, Hoseini B, Hashtarkhani S, Goshayeshi L, Kiani B. Spatial analysis of colorectal Cancer incidence in Hamadan Province, Iran: a retrospective cross-sectional study. Appl Spat Anal Policy. 2020;13(2):293–303.CrossRef
25.
Bagheri N, Furuya-Kanamori L, Doi SA, Clements AC, Sedrakyan A. Geographical outcome disparities in infection occurrence after colorectal surgery: an analysis of 58,096 colorectal surgical procedures. Int J Surg. 2017;44:117–21.PubMedCrossRef
26.
27.
McMaster R. In memoriam: George F. Jenks (1916-1996). Cartography Geogr Inf Syst. 1997;24(1):56–9.CrossRef
28.
Anselin L. Local indicators of spatial association—LISA. Geogr Anal. 1995;27(2):93–115.CrossRef
29.
Bhat D, Heiman AJ, Talwar AA, Dunne M, Amanjee K, Ricci JA. Access to breast Cancer treatment and reconstruction in rural populations: do women have a choice? J Surg Res. 2020;254:223–31.PubMedCrossRef
30.
Akinyemiju TF, Demb J, Izano MA, Rehkopf DH, Fang ML, Hiatt RA, et al. The association of early life socioeconomic position on breast cancer incidence and mortality: a systematic review. Int J Public Health. 2018;63(7):787–97.PubMedCrossRef
31.
Meijer M, Bloomfield K, Engholm G. Neighbourhoods matter too: the association between neighbourhood socioeconomic position, population density and breast, prostate and lung cancer incidence in Denmark between 2004 and 2008. J Epidemiol Community Health. 2013;67(1):6–13.PubMedCrossRef
32.
Hwang J, Bae H, Choi S, Yi H, Ko B, Kim N. Impact of air pollution on breast cancer incidence and mortality: a nationwide analysis in South Korea. Sci Rep. 2020;10(1):5392.PubMedPubMedCentralCrossRef
33.
White AJ, Keller JP, Zhao S, Carroll R, Kaufman JD, Sandler DP. Air pollution, clustering of particulate matter components, and breast cancer in the sister study: A U.S.-wide cohort. Environ Health Perspect. 2019;127(10):107002.PubMedPubMedCentralCrossRef
34.
Cheng I, Tseng C, Wu J, Yang J, Conroy SM, Shariff-Marco S, et al. Association between ambient air pollution and breast cancer risk: the multiethnic cohort study. Int J Cancer. 2020;146(3):699–711.PubMedCrossRef
35.
Saleh SAK, Adly HM, Abdelkhaliq AA, Nassir AM. Serum levels of selenium, zinc, copper, manganese, and Iron in prostate Cancer patients. Curr Urol. 2020;14(1):44–9.PubMedPubMedCentralCrossRef
36.
Lim JT, Tan YQ, Valeri L, Lee J, Geok PP, Chia SE, et al. Association between serum heavy metals and prostate cancer risk - a multiple metal analysis. Environ Int. 2019;132:105109.PubMedCrossRef
37.
Nedimovic R. Exploration for ore deposits in Kerman region. Geological Survey of Iran Report 53. 1973:247.
38.
Khorasanipour M, Esmaeilzadeh E. Geo-genic arsenic contamination in the Kerman Cenozoic magmatic arc, Kerman, Iran: implications for the source identification and regional analysis. Appl Geochem. 2015;63:610–22.CrossRef
39.
Abbasnejad A, Mirzaie A, Derakhshani R, Esmaeilzadeh E. Arsenic in groundwaters of the alluvial aquifer of Bardsir plain, SE Iran. Environ Earth Sci. 2013;69(8):2549–57.CrossRef
40.
Ebrahimi M. Evaluation of Arsenic dispersivity and the survey of the source of Arsenic in Groundwaters of Rafsanjan plain and represent the suitable ways of removal arsenic: M. Sc. Thesis (in Persian), Shahid Bahonar University of Kerman, p 203; 2009.
41.
Williams M. Arsenic in mine waters: an international study. Environ Geol. 2001;40(3):267–78.CrossRef
42.
Straif K, Benbrahim-Tallaa L, Baan R, Grosse Y, Ba S, El Ghissassi F, et al. A review of human carcinogens--part C: metals, arsenic, dusts, and fibres. Lancet Oncol. 2009;10(5):453.PubMedCrossRef
43.
López-Carrillo L, Hernández-Ramírez RU, Gandolfi AJ, Ornelas-Aguirre JM, Torres-Sánchez L, Cebrian ME. Arsenic methylation capacity is associated with breast cancer in northern Mexico. Toxicol Appl Pharmacol. 2014;280(1):53–9.PubMedCrossRef
44.
Pineda-Belmontes CP, Hernández-Ramírez RU, Hernández-Alcaraz C, Cebrián ME, López-Carrillo L. Genetic polymorphisms of PPAR gamma, arsenic methylation capacity and breast cancer risk in Mexican women. Salud Publica Mex. 2016;58:220–7.PubMedCrossRef
45.
Khanjani N, Jafarnejad A-B, Tavakkoli L. Arsenic and breast cancer: a systematic review of epidemiologic studies. Rev Environ Health. 2017;32(3):267–77.PubMedCrossRef
46.
Bardach AE, Ciapponi A, Soto N, Chaparro MR, Calderon M, Briatore A, et al. Epidemiology of chronic disease related to arsenic in Argentina: a systematic review. Sci Total Environ. 2015;538:802–16.PubMedCrossRef
47.
Aballay LR, Díaz MP, Francisca FM, Muñoz SE. Cancer incidence and pattern of arsenic concentration in drinking water wells in Córdoba, Argentina. Int J Environ Health Res. 2012;22(3):220–31.PubMedCrossRef
48.
Garland M, Morris JS, Colditz GA, Stampfer MJ, Spate VL, Baskett CK, et al. Toenail trace element levels and breast cancer: a prospective study. Am J Epidemiol. 1996;144(7):653–60.PubMedCrossRef
49.
Bulka CM, Jones RM, Turyk ME, Stayner LT, Argos M. Arsenic in drinking water and prostate cancer in Illinois counties: an ecologic study. Environ Res. 2016;148:450–6.PubMedPubMedCentralCrossRef
50.
Roh T, Lynch CF, Weyer P, Wang K, Kelly KM, Ludewig G. Low-level arsenic exposure from drinking water is associated with prostate cancer in Iowa. Environ Res. 2017;159:338–43.PubMedPubMedCentralCrossRef
51.
Rastmanesh F, Moore F, Kopaei MK, Keshavarzi B, Behrouz M. Heavy metal enrichment of soil in Sarcheshmeh copper complex, Kerman. Iran Environ Earth Sci. 2011;62(2):329–36.CrossRef
52.
Julin B, Wolk A, Johansson J-E, Andersson S-O, Andrén O, Åkesson A. Dietary cadmium exposure and prostate cancer incidence: a population-based prospective cohort study. Br J Cancer. 2012;107(5):895–900.PubMedPubMedCentralCrossRef
53.
Gallagher CM, Chen JJ, Kovach JS. Environmental cadmium and breast cancer risk. Aging (Albany NY). 2010;2(11):804.CrossRef
54.
Romaniuk А, Lyndin M, Sikora V, Lyndina Y, Romaniuk S, Sikora K. Heavy metals effect on breast cancer progression. Journal of Occupational Medicine and Toxicology. 2017;12(1):32.PubMedCrossRefPubMedCentral
55.
Fazzo L, Carere M, Tisano F, Bruno C, Cernigliaro A, Cicero MR, et al. Cancer incidence in Priolo, Sicily: a spatial approach for estimation of industrial air pollution impact. Geospat Health. 2016;11(1):43–55.CrossRef
56.
Morris LG, Sikora AG, Tosteson TD, Davies L. The increasing incidence of thyroid cancer: the influence of access to care. Thyroid. 2013;23(7):885–91.PubMedPubMedCentralCrossRef
57.
Hoseini B, Bagheri N, Kiani B, Azizi A, Tabesh H, Tara M. Access to dialysis services: a systematic mapping review based on geographical information systems. Geospat Health. 2018;13(1):577.PubMedCrossRef
58.
McGrail MR, Humphreys JS. Spatial access disparities to primary health care in rural and remote Australia. Geospat Health. 2015;10(2):358.PubMedCrossRef
59.
Kiani B, Bagheri N, Tara A, Hoseini B, Hashtarkhani S, Tara M. Comparing potential spatial access with self-reported travel times and cost analysis to haemodialysis facilities in North-eastern Iran. Geospat Health. 2018;13(2):240–6.CrossRef
60.
Kiani B, Bagheri N, Tara A, Hoseini B, Tabesh H, Tara M. Revealed access to haemodialysis facilities in northeastern Iran: factors that matter in rural and urban areas. Geospat Health. 2017;12(2):584.PubMed
61.
Mohaghegh P, Yavari P, Akbari ME, Abadi A, Ahmadi F, Shormeij Z. Relationships between family levels of socioeconomic status and distribution of breast Cancer risk factors. Iran J Cancer Prev. 2015;8(1):53–9.PubMedPubMedCentral
62.
Vicens GR, Zafra MS, Moreno-Crespi J, Ferrer BC, Marcos-Gragera R. Incidence variation of prostate and cervical cancer according to socioeconomic level in the Girona health region. BMC Public Health. 2014;14:1079.PubMedPubMedCentralCrossRef
63.
Shafique K, Oliphant R, Morrison DS. The impact of socio-economic circumstances on overall and grade-specific prostate cancer incidence: a population-based study. Br J Cancer. 2012;107(3):575–82.PubMedPubMedCentralCrossRef
64.
Goshayeshi L, Ghaffarzadegan K, Khooei A, Esmaeilzadeh A, Rahmani Khorram M, Mosannen Mozaffari H, et al. Prevalence and clinicopathological characteristics of mismatch repair-deficient colorectal carcinoma in early onset cases as compared with late-onset cases: a retrospective cross-sectional study in northeastern Iran. BMJ Open. 2018;8(8):e023102.PubMedPubMedCentralCrossRef
65.
Goshayeshi L, Khooiee A, Ghaffarzadegan K, Rahmani Khorram M, Bishehsari F, Hoseini B, et al. Screening for Lynch syndrome in cases with colorectal carcinoma from Mashhad. Arch Iran Med. 2017;20(6):332–7.PubMed
66.
Khorram MR, Goshayeshi L, Maghool F, Bergquist R, Ghaffarzadegan K, Eslami S, et al. Prevalence of mismatch repair-deficient colorectal adenoma/polyp in early-onset, advanced cases: a cross-sectional study based on Iranian hereditary colorectal Cancer registry. J Gastrointest Cancer. 2020.
67.
Ozanne EM, Loberg A, Hughes S, Lawrence C, Drohan B, Semine A, et al. Identification and management of women at high risk for hereditary breast/ovarian cancer syndrome. Breast J. 2009;15(2):155–62.PubMedCrossRef
68.
Beebe-Dimmer JL, Kapron AL, Fraser AM, Smith KR, Cooney KA. Risk of prostate Cancer associated with familial and hereditary Cancer syndromes. J Clin Oncol. 2020;38(16):1807–13.PubMedCrossRefPubMedCentral
69.
Thompson DJ, Genovese G, Halvardson J, Ulirsch JC, Wright DJ, Terao C, et al. Genetic predisposition to mosaic Y chromosome loss in blood. Nature. 2019;575(7784):652–7.PubMedPubMedCentralCrossRef
70.
Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266(5182):66–71.PubMedCrossRef
71.
Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995;378(6559):789–92.PubMedCrossRef
72.
Pal T, Permuth-Wey J, Betts JA, Krischer JP, Fiorica J, Arango H, et al. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer. 2005;104(12):2807–16.PubMedCrossRef
73.
Claus EB, Schildkraut JM, Thompson WD, Risch NJ. The genetic attributable risk of breast and ovarian cancer. Cancer. 1996;77(11):2318–24.PubMedCrossRef
74.
Goovaerts P, Jacquez GM. Accounting for regional background and population size in the detection of spatial clusters and outliers using geostatistical filtering and spatial neutral models: the case of lung cancer in Long Island, New York. Int J Health Geogr. 2004;3(1):14.PubMedPubMedCentralCrossRef
75.
Zhang C, Luo L, Xu W, Ledwith V. Use of local Moran's I and GIS to identify pollution hotspots of Pb in urban soils of Galway, Ireland. Sci Total Environ. 2008;398(1–3):212–21.PubMedCrossRef
76.
Li K, Lin G-Z, Li Y, Dong H, Xu H, Song S-F, et al. Spatio-temporal analysis of the incidence of colorectal cancer in Guangzhou, 2010–2014. Chin J Cancer. 2017;36(1):60.PubMedPubMedCentralCrossRef
77.
Goovaerts P, Jacquez GM. Detection of temporal changes in the spatial distribution of cancer rates using local Moran’s I and geostatistically simulated spatial neutral models. J Geogr Syst. 2005;7(1):137–59.PubMedPubMedCentralCrossRef
Metadata
Title
Spatio-temporal mapping of breast and prostate cancers in South Iran from 2014 to 2017
Authors
Mahdieh Montazeri
Benyamin Hoseini
Neda Firouraghi
Fatemeh Kiani
Hosein Raouf-Mobini
Adele Biabangard
Ali Dadashi
Vahideh Zolfaghari
Leila Ahmadian
Saeid Eslami
Robert Bergquist
Nasser Bagheri
Behzad Kiani
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2020
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-020-07674-8

Other articles of this Issue 1/2020

BMC Cancer 1/2020 Go to the issue

Research article

Association between five types of Tumor Necrosis Factor-α gene polymorphism and hepatocellular carcinoma risk: a meta-analysis

Research article

Predictive value of gamma-glutamyl transpeptidase to lymphocyte count ratio in hepatocellular carcinoma patients with microvascular invasion

Research article

The Axin2-snail axis promotes bone invasion by activating cancer-associated fibroblasts in oral squamous cell carcinoma

Research article

Pulmonary cavitation in patients with thyroid cancer receiving antiangiogenic agents

Research article

Identification of microRNAs and their Endonucleolytic Cleavaged target mRNAs in colorectal cancer

Research article

Management of medically inoperable and tyrosine kinase inhibitor-naïve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a retrospective multi-institutional analysis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits